Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The cyclic adenosine 3',5'-monophosphate signalling pathway is now recognised to transduce signals in a compartmentalised manner such that individual stimuli only engage a subset of the pathway components that are physically constrained within defined subcellular locales, thus resulting in a precise functional outcome. As we are starting to appreciate the complexity of the spatial organisation and of the temporal regulation of this pathway, it is becoming clear that disruption of local signalling may lead to pathology and that local manipulation of cAMP signals may offer alternative approaches to treat disease.

Original publication

DOI

10.1016/j.coph.2011.09.014

Type

Journal article

Journal

Curr Opin Pharmacol

Publication Date

12/2011

Volume

11

Pages

649 - 655

Keywords

Animals, Biological Transport, Cyclic AMP, Heart Diseases, Humans, Molecular Targeted Therapy, Myocytes, Cardiac, Phosphodiesterase Inhibitors, Second Messenger Systems